5‐(2‐Methyl‐2‐nitro‐1‐phenylpropyl)‐4‐phenyl‐1,2,3‐selenadiazole

By  

Acta Crystallographica Section E, Vol. 63, Iss. 12, 2007-12 ,pp. : o4676-o4676

John Wiley & Sons Inc

Access to resources Recommend Favorite

(E)‐3‐[(1,5‐Dimethyl‐3‐oxo‐2‐phenyl‐1H‐pyrazol‐4‐ylimino)methyl­ene]phenyl 4‐methyl­benzene­sulfonate

By  

Acta Crystallographica Section E, Vol. 62, Iss. 12, 2006-12 ,pp. : o5525-o5526

John Wiley & Sons Inc

Access to resources Recommend Favorite

1′‐Methyl‐4′‐phenyl­indan‐2‐spiro‐2′‐pyrrolidine‐3′‐spiro‐1′′‐cyclo­octane‐1,3,2′′‐trione

By  

Acta Crystallographica Section E, Vol. 62, Iss. 12, 2006-12 ,pp. : o5551-o5553

John Wiley & Sons Inc

Access to resources Recommend Favorite

1‐Methyl‐2‐phenyl‐1H‐indole

By  

Acta Crystallographica Section E, Vol. 63, Iss. 4, 2007-04 ,pp. : o1963-o1964

John Wiley & Sons Inc

Access to resources Recommend Favorite

N‐[(1S,2S,3R)‐2‐Bromo‐3‐(tert‐butyl­di­phenyl­silyl­oxy)‐1‐phenyl‐4‐(phenyl­sulfonyl)­butyl]‐4‐methyl­benzene­sulfon­amide

By  

Acta Crystallographica Section E, Vol. 60, Iss. 12, 2004-12 ,pp. : o2290-o2292

John Wiley & Sons Inc

Access to resources Recommend Favorite